Navigation Links
AMDL Announces New Corporate Video
Date:6/24/2008

TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), http://www.amdl.com, a leader in specialty pharmaceuticals headquartered in Tustin, Ca. with operations in Shenzhen, Jiangxi, and Jilin, China, announced today it has released a new Corporate video which is available for viewing on the Company's website at http://www.amdl.com.

According to Gary Dreher, Chief Executive Officer of AMDL, "We have created a new, three minute company video to highlight AMDL's unique China-centric pharmaceutical business. It also illuminates our significant business prospects." Click on (NEWS at http://www.amdl.com) to view the video.

About AMDL:

AMDL, Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this Document include certain predictions and projections that are forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this Document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, AMDL Inc.'s operating history, uncertainties related to the Company's access to additional capital, competition and dependence on key management.

Contact: Kristine Szarkowitz

AMDL Communications

206/310-3523

kszarkowitz@amdl.com


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... and deep lines by smoothing and tightening the skin of the face to ... to address facial aging with very little downtime, Silhouette Instalift is a novel, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... women growing up with a schizophrenic mother in a unique, personal perspective through ... specializes in treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning of October ... emergency medical call when he lost control of his patrol car. The vehicle overturned ... vehicle, he was transported to Atlanta Medical Center, where he later succumbed to his ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Castle Dermatology ... in several ways to restore a more youthful appearance to the face. Dr. Peyman ... Sculptra, along with a variety of other treatments, to rejuvenate and renew the facial ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 ... company advancing technologies designed to address rare, emerging ... Chitra Edwin , Ph.D., RAC, as Senior ... Edwin will provide leadership for all U.S. and ... approvals, preparation of regulatory submissions, serving as the ...
(Date:12/7/2016)...  Urinary catheters are used for patients suffering ... disorders. Urinary catheters include indwelling (Foley) catheter, intermittent ... Foley catheter is a flexible tube with lumens ... inserted into the bladder through the urethra and ... at one end of the catheter is inflated ...
(Date:12/7/2016)... , Dec. 7, 2016  Palatin Technologies, ... has closed on a previously disclosed underwritten public ... Canaccord Genuity acted as sole book-running manager, Roth ... Capital Markets acted as co-manager for the offering. ... $15.4 million in net proceeds, allowing us to ...
Breaking Medicine Technology: